Literature DB >> 13521767

Some aspects of the absorption, distribution, and excretion of amphotericin B in man.

D B LOURIA.   

Abstract

Entities:  

Keywords:  FUNGICIDES/metabolism

Mesh:

Substances:

Year:  1958        PMID: 13521767

Source DB:  PubMed          Journal:  Antibiotic Med Clin Ther (New York)        ISSN: 0570-3107


× No keyword cloud information.
  26 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  5-fluorocytosine and amphotericin B in bronchial secretions.

Authors:  J E Pennington; E R Block; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

3.  The Use of Amphotericin B in Selected Cases of Chorioretinitis.

Authors:  H F Falls; C L Giles
Journal:  Trans Am Ophthalmol Soc       Date:  1959

4.  Effects of amphotericin B in vitro on perfect and imperfect strains of Allescheria boydii.

Authors:  H S Nielsen
Journal:  Appl Microbiol       Date:  1967-01

5.  Neutrophil toxicity of amphotericin B.

Authors:  C J Chunn; P R Starr; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

6.  Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B.

Authors:  M S Collins; D Pappagianis
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

7.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

8.  In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.

Authors:  J W Brandsberg; M E French
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

9.  Amphotericin B therapy in an anephric patient.

Authors:  H A Feldman; J D Hamilton; R A Gutman
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

Review 10.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.